Please use this identifier to cite or link to this item:
https://hdl.handle.net/10137/5846
Title: | Use of terbinafine for tinea in Australian Aboriginal communities in the Top End. |
Authors: | Koh KJ Parker CJ Ellis DH Pruim B Leysley L Currie BJ |
Citation: | The Australasian journal of dermatology 2003-11; 44(4): 243-9 |
Abstract: | Tinea of the skin and nails is a common problem in remote Aboriginal communities of the Top End of Australia. A retrospective study was performed on data collected from 104 patients from several indigenous communities. Worksheets were filled in by district medical officers and rural general practitioners, detailing the extent of the tinea. Patients were prescribed between 4 and 12 weeks of 250 mg daily oral terbinafine. Fifty-two patients were followed up, with 45 having a good response to treatment (87%) and with 22 of these patients having full clearance of tinea (42%). A prospective study with 44 subjects was performed. The extent of the tinea was documented and fungal scrapings/clippings were taken. Forty subjects were recruited and given oral terbinafine (2-12 weeks depending on skin/nail involvement) or topical terbinafine if oral treatment was contraindicated. Twenty-five of the 40 (63%) subjects were reviewed. Twenty-three (92%) subjects that were followed up improved clinically, with 8/25 (32%) clearing completely. Twenty (80%) of followed-up patients complied fully with treatment. Terbinafine was found to be a well-tolerated and effective treatment of tinea of the skin and nails. |
Click to open PubMed article: | https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed//14616489 |
Journal title: | The Australasian journal of dermatology |
Publication Date: | 2003-11 |
ISSN: | 0004-8380 |
Type: | Comparative Study Journal Article |
URI: | https://hdl.handle.net/10137/5846 |
Appears in Collections: | (a) NT Health Research Collection |
Files in This Item:
There are no files associated with this item.
Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.